% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Gioran:140583,
author = {Gioran, Anna and Piazzesi, Antonia and Bertan, Fabio and
Schroer, Jonas and Wischhof, Lena and Nicotera, Pierluigi
and Bano, Daniele},
title = {{M}ulti-omics identify xanthine as a pro-survival
metabolite for nematodes with mitochondrial dysfunction.},
journal = {The EMBO journal},
volume = {38},
number = {6},
issn = {0261-4189},
address = {Hoboken, NJ [u.a.]},
publisher = {Wiley},
reportid = {DZNE-2020-06905},
pages = {e99558},
year = {2019},
abstract = {Aberrant mitochondrial function contributes to the
pathogenesis of various metabolic and chronic disorders.
Inhibition of insulin/IGF-1 signaling (IIS) represents a
promising avenue for the treatment of mitochondrial
diseases, although many of the molecular mechanisms
underlying this beneficial effect remain elusive. Using an
unbiased multi-omics approach, we report here that IIS
inhibition reduces protein synthesis and favors catabolism
in mitochondrial deficient Caenorhabditis elegans We unveil
that the lifespan extension does not occur through the
restoration of mitochondrial respiration, but as a
consequence of an ATP-saving metabolic rewiring that is
associated with an evolutionarily conserved phosphoproteome
landscape. Furthermore, we identify xanthine accumulation as
a prominent downstream metabolic output of IIS inhibition.
We provide evidence that supplementation of FDA-approved
xanthine derivatives is sufficient to promote fitness and
survival of nematodes carrying mitochondrial lesions.
Together, our data describe previously unknown molecular
components of a metabolic network that can extend the
lifespan of short-lived mitochondrial mutant animals.},
keywords = {Adenosine Triphosphate: metabolism / Animals /
Caenorhabditis elegans: drug effects / Caenorhabditis
elegans: growth $\&$ development / Caenorhabditis elegans:
metabolism / Caenorhabditis elegans Proteins: genetics /
Caenorhabditis elegans Proteins: metabolism / Insulin:
chemistry / Insulin-Like Growth Factor I: antagonists $\&$
inhibitors / Longevity / Metabolome / Mitochondria: drug
effects / Mitochondria: metabolism / Mitochondria: pathology
/ Mitochondrial Diseases: metabolism / Mitochondrial
Diseases: pathology / Mitochondrial Diseases: prevention
$\&$ control / Proteome / Transcriptome / Xanthine:
administration $\&$ dosage / Xanthine: metabolism /
Caenorhabditis elegans Proteins (NLM Chemicals) / Insulin
(NLM Chemicals) / Proteome (NLM Chemicals) / Xanthine (NLM
Chemicals) / Insulin-Like Growth Factor I (NLM Chemicals) /
Adenosine Triphosphate (NLM Chemicals)},
cin = {AG Bano / AG Nicotera},
ddc = {570},
cid = {I:(DE-2719)1013003 / I:(DE-2719)5000018},
pnm = {341 - Molecular Signaling (POF3-341) / 342 - Disease
Mechanisms and Model Systems (POF3-342)},
pid = {G:(DE-HGF)POF3-341 / G:(DE-HGF)POF3-342},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:30796049},
pmc = {pmc:PMC6418696},
doi = {10.15252/embj.201899558},
url = {https://pub.dzne.de/record/140583},
}